Abstract
Currently, metabolic syndrome is manifested by symptoms such as obesity, weight gain and excess fat accumulation among the population, which, as a result, is manifested by diseases such as diabetes mellitus and insulin resistance among the population. According to the World Health Organization, the number of diabetes mellitus patients currently exceeds 400 million worldwide. In 2019 alone, diabetes ranked ninth in terms of causes of death, leading to approximately 1.5 million deaths. The prevalence of obesity and diabetes has reached pandemic levels over the past 50 years, which in turn leads to the development of metabolic syndrome in the body and dysfunction of all organs and tissues of the body, including lung tissue. This disease, as a result of the accumulation of hypoxic cells around organs and tissues, causes respiratory diseases such as pneumonia, bronchial asthma, pulmonary hypertension, acute respiratory distress syndrome (ARDS) and obstructive sleep apnea syndrome, disruption of lung homeostasis and the immune system, and changes in the population of inflammatory cells in the lung in obesity have been studied by a number of foreign researchers. Scientists from the CIS countries have elucidated the complex pathophysiological mechanisms of obesity and diabetes, the presence of mitochondrial dysfunction, endoplasmic reticulum stress in this process, and the mechanisms of changes in cellular and intracellular redox balance. In our country, few studies have been conducted on non-respiratory lung function disorders in metabolic syndrome, their early diagnosis, and correction of identified changes. For this reason, the implementation of this scientific research is of scientific and practical importance.
Research objective: To observe the effect of a traditional and modified ketogenic diet on non-respiratory lung functions in metabolic syndrome and analyze the results obtained.